Cryo cell International Inc (CCEL) Annual Income Statement

Annual · GAAP · USD millions
Access CCEL quarterly income statements →
The data below summarizes Cryo cell International Inc's income statement results from Nov 30 2021 to Nov 30 2025, enabling period-by-period comparison of operating performance.
Annual Report, GAAP in USD millions
ITEM
(Nov 30 2025)
2025
(Nov 30 2024) (Nov 30 2023) (Nov 30 2022) (Nov 30 2021)
Revenues
Revenue From Contract With Customer Including Assessed Tax31.57
Total Revenue31.57
Costs & Expenses
Cost of Goods and Services Sold7.38
Gross Profit24.19
Selling, Administration, Marketing18.22
Depreciation & Amortization0.75
Research and Development Expense0.38
Other Asset Impairment Charges4.36
Other Operating Expense / -Income0.00
Total operating costs including COS31.08
Operating income / -loss0.48
Interest Expense0.00
Net Interest Expense / -Income0.00
Marketable Securities, Unrealized Gain (Loss)-0.81
Other loss / -income1.56
Total costs & expenses33.90
Income & Taxes
Income / -loss before income taxes-2.34
Income taxes expenses / -benefit0.09
Income after income taxes-2.43
Net income / -loss of other equity0.00
Income / -loss from continuing operations-2.43
Net income / -loss-2.43
Income / -loss to shareholder-2.43
EBIT-2.34
EBITD-1.35
EBITDA-1.33
Earnings Per Share
Basic EPS (excl. extra items)-0.30
Basic Net EPS-0.30
Basic shares outstanding (Mill. of Units)8.07
Diluted Net EPS-0.30
Diluted average shares (Mill. of Units)8.07
Dividend per share0.00
4 historic quarters locked

Sign in to unlock the full Cryo cell International Inc income statement history.

About Cryo Cell International Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 27, 2026
  • Original filing: ccel-20251130.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.